echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > "Rational Use of Medicines·China Action" 2020 National Experience Exchange Summary and 202...

    "Rational Use of Medicines·China Action" 2020 National Experience Exchange Summary and 202...

    • Last Update: 2021-05-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 17, managers from health administrative departments across the country, medical institution pharmacy management and pharmacy service professionals, experts and scholars in the fields of pharmacoeconomics, health economics, medical security, etc.


    "Rational Use of Medicines·China Action" 2020 National Experience Exchange Summary and 2021 Launch Conference

    The launching ceremony of the national collection of typical experiences and innovative cases of rational drug use

    The launching ceremony of the national collection of typical experiences and innovative cases of rational drug use The launching ceremony of the national collection of typical experiences and innovative cases of rational drug use

    The conference invited relevant persons in charge of the Medical Administration and Hospital Administration of the National Health Commission to conduct authoritative interpretations of policies related to rational use of drugs, and conduct work arrangements for health administrative departments and medical institutions at all levels to strengthen pharmaceutical management and promote rational use of drugs.


    At the same time, the main forum of the conference also released typical cases such as "Promoting the rational use of drugs-government organizations, anti-epidemic models, annual figures, subject teams, academic activities" in 2020, so that the power of models will inspire the whole industry to be better.


    Xing Ruoqi, deputy director of the Medical Administration and Medical Administration Bureau of the National Health Commission, said in his speech that strengthening the management of rational drug use is of great significance for ensuring the quality and safety of medical care, reducing the burden of medical treatment and maintaining people’s health.


    Xing Ruoqi pointed out that at present, the people's demand for rational drug use is increasing, the level of drug treatment for some diseases needs to be improved, and the personalized drug needs of special groups such as the elderly should be paid more attention.


    Xing Ruoqi said that the "Rational Use of Medicines·China Action" has built a good platform for the exchange and summary of management experience of rational use of medicines, discussion and solution of current problems, and clarification of the next step of work.


    At the meeting, Wang Manli, deputy director of the Medical Management Division of the Medical Administration and Hospital Administration of the National Health Commission, carried out authoritative policies around the "Opinions on Strengthening the Management of Pharmaceutical Affairs in Medical Institutions and Promoting Rational Use of Medicines" jointly issued by the National Health Commission and other 6 departments.


    According to Li Wenxiu, deputy director of the Hainan Provincial Health Commission, in order to support the construction of the Hainan Free Trade Port, in 2019, the National Health Commission and other four departments jointly issued the "Implementation Plan for Supporting the Construction of Boao Lecheng International Medical Tourism Pioneer Zone".


    Li Wenxiu said that not long ago, the National Development and Reform Commission and the Ministry of Commerce jointly issued the "Opinions on Supporting the Construction of Hainan Free Trade Port to Relax Certain Special Measures for Market Access", clarifying that it will increase support for drug access and allow Hainan Province to carry out Internet drug sales.


    Wu Jinglei, director of the Shanghai Municipal Health Commission, said that pharmacy services are an important part of clinical diagnosis and treatment.


    Song Shigui, deputy director of the Sichuan Provincial Health Commission, pointed out that Sichuan Province, in accordance with the ideas of highlighting key points, centralized governance, sound mechanisms, and continuous improvement, strives to improve the management level of rational drug use in medical institutions throughout the province.


    Wang Yancheng, the second-level inspector of the Gansu Provincial Health Commission, said that Gansu Province has strengthened the management of drug allocation in medical institutions, requiring medical institutions to give priority to the use of national centralized procurement of drugs and national medical insurance negotiation drugs; at the same time, it has strengthened the supervision and assessment of rational use of drugs.


    Hu Yin, director of the Office of the National Monitoring Network for Rational Use of Drugs, shared the status of clinical drug monitoring carried out in 1,680 sample hospitals across the country and analyzed relevant data.


    Hu Yin pointed out that in the future, the National Monitoring Office for Rational Use of Drugs will strengthen research on special topics of rational use of drugs in various provinces (municipalities), and conduct special project analysis and evaluation for key diseases and key drugs in key disease systems.


    Shi Luwen, former director of Peking University International Research Center for Pharmaceutical Management, shared his thoughts and insights on the promotion of rational drug use in the context of the linkage of the three medical institutions.


    Reducing the use rate of intravenous infusion in hospitalized patients is one of the top ten national medical quality and safety improvement goals in 2021.


    Antimicrobial drug supply catalog management is one of the key points of antimicrobial drug clinical application management.
    Pang Chongjie, director of the Department of Infectious Diseases at the General Hospital of Tianjin Medical University and director of the Tianjin Infectious Disease Quality Control Center, said that Tianjin adheres to the principle of meeting clinical needs as the center.
    In terms of antibacterial drug selection, it insists on preferential selection of the national formulary and national essential drug list.
    , Antibacterial drugs in the National Medical Insurance Catalogue, classify antibacterial drugs by species, select safe, effective, and economical species, consider different hospital discipline settings and the medication needs of common and frequently-occurring diseases, take into account the use of pediatric drugs, and pass the quality control of infectious diseases The center and the experts of the Pharmaceutical Quality Control Center discussed the selection and classification of antibacterial drugs that must be retained, best retained, retained, and eliminated, and the procurement catalog was affected through the hierarchical management catalog.
    The Tianjin Infectious Diseases Quality Control Center (Antimicrobial Drug Management Team) requires hospitals to provide antimicrobial drug supply catalogues and hierarchical management catalogues during the annual antibacterial drug clinical use inspections and medical history reviews.
    The catalogue has a high drug resistance rate and many adverse reactions.
    , Insufficient evidence-based medicine evidence, illegal use of outstanding drugs, it is recommended that medical institutions clear out the supply list, receive medical institutions welcome and be implemented.

    Deng Haihua, president and party secretary of the Health News, said that the Health News has always attached great importance to publicity and reports on the rational use of drugs.
    In addition to setting up special pages for propaganda and reporting on rational use of medicines in traditional paper media, such as medical guides and medical observations, in order to serve medical workers across the country more accurately, the official WeChat service account and video account of "Rational Use of Medicines China Action" were also opened in early 2021.
    , Interpret national policies in a better and more timely manner, disseminate local experience, and play the social responsibilities of mainstream media.

    Deng Haihua said that in addition to the convening of this rational drug use summary and kick-off conference, in addition to inviting clinical pharmacy experts in the industry to exchange experiences and share practices, it also hopes to make full use of the advantages of public opinion guidance of the health newspaper industry to find excellence, discover bright spots, and explore Model, set an example, promote experience, further improve the industry and society's understanding of the core information of rational drug use, implement relevant national policy documents, and jointly improve the level of rational drug use.

    At the meeting, Xiao Jingdan, vice president of the Health News Agency, introduced the typical experience of rational drug use across the country in 2021 and the detailed rules for the collection of innovative cases.
    The solicitation activities mainly focus on the management of rational use of drugs, including the hospital’s experience and practices in drug allocation management, rational use of drugs, pharmacy service optimization, pharmacy talent team building, industry standard supervision, scientific popularization of rational use of drugs, and three-medicine linkage, etc.
    , works The format includes text and video.
    The text is within 3000 words and the video is within 3 minutes.

    From now until December 25, medical institutions can submit their works to the designated email address (yongjizhu@126.
    com), and the case will be submitted through the column of "Health News", the WeChat official account of China Action for Rational Use of Medicines, and the WeChat video account.
    And the Health News New Media Matrix for display.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.